Little Ox — doctor-designed UK supplements

Cheap vs Expensive NMN: What Are You Actually Paying For?

Cheap vs Expensive NMN: What Are You Actually Paying For?

NMN prices vary enormously. A higher price does not automatically mean a better product, and a lower price does not automatically mean corners have been cut. The useful question is what you are actually getting for the money.

What is worth paying for?

  • Clear ingredient identity: the label should state what form of NMN is used.
  • A meaningful daily serving: compare the recommended daily amount, not just the capsule count.
  • Independent testing: look for transparent quality checks and Certificates of Analysis.
  • Manufacturing controls: quality systems matter more than luxury packaging.
  • Useful additional ingredients: a combined formula can cost more if it genuinely contains additional active ingredients at declared amounts.

What does not necessarily justify a premium?

Expensive packaging, celebrity promotion, influencer spend and a large retail margin do not make the NMN molecule better. If two products offer comparable daily servings and transparent testing, compare the real cost rather than assuming the premium brand must be superior.

Little Ox pricing

NMN Pure is currently £7.99 one-off and provides a 500mg daily serving of β-NMN.

NMN Plus is £9.99 one-off and provides the same 500mg daily serving with trans-resveratrol.

Both have a live monthly Subscribe & Save option at 15% off. Annual options are £69 for NMN Pure and £84.99 for NMN Plus, equivalent to approximately £5.75 and £7.08 per month respectively.

Important correction: the annual NMN Plus price is not “67% off” the one-off annualised cost. At current prices it is about 29% lower than buying twelve £9.99 one-off units.

Compare value properly

7 things to compare before buying NMN →
See all Pure, Plus, subscription and annual options →

This article is general information and does not constitute medical advice.

Back to blog

Leave a comment

Please note, comments need to be approved before they are published.